期刊文献+

初诊成人自身免疫性糖尿病心血管疾病风险评估 被引量:2

Evaluation of the cardiovascular disease risk in newly diagnosed adult with latent autoimmune diabetes
下载PDF
导出
摘要 目的:临床评估初诊成人隐匿性自身免疫糖尿病(Latent autoimmune diabetes in adults,LADA)心血管疾病风险。方法:初诊糖尿病(Diabetes mellitus,DM)患者,共132例,经糖尿病自身抗体检测后分为LADA组和2型糖尿病(Type 2diabetes mellitus,T2DM)组(其中LADA组60例,T2DM组72例)。同时从体检中心选取与LADA组年龄、体重指数相匹配的健康对照(Normal controls,NC)组46例。观察高敏C反应蛋白(High-sensitivity C-reactive protein,hs-CRP)水平和颈动脉内膜中层厚度(Carotid intima medial thickness,CIMT),比较三组患者之间的hs-CRP、CIMT水平。结果:1.hs-CRP、CIMT水平在LA-DA组显著高于NC组(P<0.01,P<0.05),LADA不伴动脉硬化(Atherosclerosis,AS)组与NC组比较,hs-CRP、CIMT水平升高达统计学差异(P<0.05)。应用hs-CRP水平进行心血管疾病风险分层后,LADA组与NC组比较,心血管疾病风险中、高危组比例明显升高(P<0.001)。2.将hs-CRP、CIMT水平分别在LADA组和T2DM组之间、LADA不伴AS组和T2DM不伴AS组之间比较,未达统计学差异(P>0.05)。LADA组与T2DM组比较AS发生率差异未达统计学意义(P=0.489)。AS斑块发生率在LADA组、T2DM组两组间比较未见统计学差异(P=0.920)。LADA组与T2DM组hs-CRP危险分层,心血管疾病风险中、高危组比较均未见统计学差异(P>0.05,P>0.05)。3.LADA组中,CIMT与LDL-C、FPG、2hPG、HbA1c、hs-CRP均呈显著直线正相关(P=0.001~0.044)。结论:初诊LADA患者hs-CRP、CIMT水平升高,提示心血管疾病风险增加;与初诊T2DM比较心血管疾病风险无显著差异。 Objective:To investigate the cardiovascular disease risk of the newly diagnosed adult latent autoimmune diabetes (LADA). Methods:After determination of diabetes autoantibodies, 132 cases newly diagnosed diabetes were divided into LADA group (n = 60) and type 2 diabetes mellitus (T2DM) group (n = 72). At the same time,46 cases from physical examination center were se-lected in normal controls group (NC group) , whoes age and body mass index matched with LADA group. The high-sensitivity C-reac-tive protein (hs-CRP) level and the carotid intima medial thickness (CIMT) in three groups were compared. Results:l. The concen-tration of hs-CRP and the levels of CIMT in the LADA group was significantly higher than NC group, (P 〈 0.01, P 〈 0.05 ) , and in LADA without atherosclerosis (AS) group also higher than NC group ( P 〈 0.05 ). The risk stratification of cardiovascular disease u-sing the levels of hs-CRP, the percentage of moderate risk group and high risk group in the LADA group was markedly elevated than NC group( P 〈 0. 001, P 〈 0.001 ). 2. Through compared the levels of hs-CRP and CIMT, there were no significant difference between LADA group and T2DM group (P 〉 0.05 ), also were between LADA without AS group and T2DM without AS group( P 〉 0. 05 ). There were no statistical significance between LADA group and T2DM group in the incidence of AS and carotid atherosclerosis plaque( P = 0. 489, P = 0.920) , the proportion of moderate risk group and high risk group of cardiovascular disease between two group were also no significant difference(P 〉0.05, P 〉0.05). 3. In LADA group, LDL-C, FPG, HbAlc, 2hPG, hs-CRP showed a significant linear correlation with CIMT( P = 0. 0014). 044 ). Conclusion:The elevated hs-CRP levels and CIMT levels in newly diagnosed LADA indica-ted that its risk of cardiovascular disease was increased. The hs-CRP and CIMT levels in newly diagnosed LADA and newly diagnosed T2DM was no significant difference .
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2012年第12期1129-1133,1135,共6页 Chinese Journal of Immunology
关键词 成人隐匿性自身免疫糖尿病 高敏C-反应蛋白 颈动脉内膜中层厚度 心血管疾病 Latent autoimmune diabetes in adults High-sensitivity C-reactive protein Carotid intima-media thickness Cardiovascular disease
  • 相关文献

参考文献11

  • 1Qasim A N, Budharaju V, Mehta N Net al. Gender differences in the association of C-reactive protein with coronary artery calcium in Type-2 diabetes [ J ]. Chn Endocrinol ( Oxf ), 2011 , 74 ( 1 ) :44 -50.
  • 2Distiller L A, Joffe B I, Melville V et al. Carotid artery intima-media complex thickening in patients with relatively long-surviving type 1 di- abetes mellitus [ J ]. J Diabetes Complications, 2006, 20 ( 5 ) : 280 -284.
  • 3Pozzilli P, Di Mario U. Autoimmune diabetes not requiring insulin at diagnosis ( latent autoimmune diabetes of the adult ) : definition, char- acterization, and potential prevention [ J ]. Diabetes Care, 2001 , 24 (8) :1460-1467.
  • 4吴晓燕,汤旭磊,高林.2型糖尿病免疫炎症的初步探讨[J].中国免疫学杂志,2007,23(10):944-946. 被引量:15
  • 5王黎光,吴寿岭,王丽晔,刘秀荣,李云,李冬青,戚长春,韩艳华,王庆蕊,刘爱华.新发糖尿病人群血清超敏C反应蛋白水平及其影响因素[J].中华内分泌代谢杂志,2012,28(1):32-35. 被引量:9
  • 6Biasucci L M, CDC,AHA. CDC/AHA Workshop on Markers of In- flammation and Cardiovascular Disease: Application to Clinical and Public Health Practice : clinical use of inflammatory markers in pa- tients with cardiovascular diseases : a background paper [ J ]. Circula- tion, 2004 , 110 ( 25 ) : e560-e567.
  • 7O' Leary D H, Polak J F, Wolfson S K J R et al. Use of sonography to evaluate carotid atheroselerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group [ J ]. Stroke , 1991 ,22(9) :1155-1163.
  • 8Salonen J T, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression [ J ]. Circulation, 1993 , 87 ( 3 Suppl) : I156-1165.
  • 9颜湘,张峥,欧阳玲莉,胡敏,周智广.LADA与2型糖尿病患者的临床对比[J].中国医师杂志,2001,3(11):826-828. 被引量:5
  • 10Myhill P, Davis W A, Bruce D Get al. Chronic complications and mortality in community-based patients with latent autoimmune diabe- tes in adults:the Fremantle Diabetes Study[ J]. Diabet Med,2008, 25 (10) : 1245-1250.

二级参考文献20

  • 1陈玉堂,田慧.糖尿病合并高血压对微血管病变患病率的影响[J].中华内分泌代谢杂志,1998,14(2):106-108. 被引量:41
  • 2[1]Eguchi K,Yagame M,Suzuki D et al.Significance of high level of serum IgA and IgA-classcirculating immune complexes (IgA-CIC) in patients with non-insulin dependent diabetes mellitus[J].J Diabetes Complication,1995 ;9(1):42-48.
  • 3[2]Barbara M,Brooks-Worrell,Rattan Juneja et al.Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients[J].Diabetes,1999;48(5):983-988.
  • 4[3]Mosmann T R,Coffman R l.Th1 and Th2 cella different fatterns of lymphokine secretion lead to different functional properties[J].Annu Rev Immunol,1989;7:145-173.
  • 5[4]Mosmann T R,Sad S.The expanding universe of T-cell subets:Th1,Th2 and more[J].Immunol Today,1996;17(3):138-146.
  • 6[5]Katz J D,Benoist C,Mathis D T et al.helper cell subsets in insulindependent diabetes[J].Sicience,1995 ;268(5214):1185-1188.
  • 7[6]Almawi W Y,Tamin H,Azar S T.Clinical review 103:T helper type 1 and 2 cytokines mediate the onsetand progression of type 1 (insulin dependent) diabetes[J].J Clin Endocrinol Metab,1999;84(5):1497-1502.
  • 8[7]John A,Colwell M D.Inflammation and diabetic vascular complications[J].Diabetes Care,1999;22(12):1927-1928.
  • 9[8]Ford ES.Body mass index,diabetes,and c-reactive protein among U S adults[J].Diabetes Care,1999;22(12):1971-1977.
  • 10[9]Barzilay J I,Abaham I,Heckbert S R et al.The relation of markers of inflammation to the development of glucose disorders in the elderly:the cardiovascular health study[J].Diabetes,2001 ;50(10):2384-2389.

共引文献26

同被引文献12

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部